PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Oncotarget: Fgr and Numb in retinoic differentiation and G0 arrest of non-APL AML cells

In sum the Oncotarget data support a paradigm where signaling molecules bound to a Numb scaffold in a signalsome are activated by RA-induced Fgr expression

Oncotarget: Fgr and Numb in retinoic differentiation and G0 arrest of non-APL AML cells
2021-07-23
(Press-News.org) Oncotarget published "Role for Fgr and Numb in retinoic acid-induced differentiation and G0 arrest of non-APL AML cells" which reported that retinoic acid is a fundamental regulator of cell cycle and cell differentiation.

Using a leukemic patient-derived in vitro model of a non-APL AML, these authors previously found that RA evokes activation of a macromolecular signaling complex, a signalosome, built of numerous MAPK-pathway-related signaling molecules; and this signaling enabled Retinoic-Acid-Response-Elements to regulate gene expression that results in cell differentiation/cell cycle arrest. Toward mechanistic insight into the nature of this novel signaling, they now find that the NUMB cell fate determinant protein is an apparent scaffold for the signalosome.

Numb exists in the cell bound to an ensemble of signalosome molecules, including Raf, Lyn, Slp-76, and Vav.

Fgr binds NUMB, which is associated with phosphorylation of NUMB and enhanced NUMB-binding and phosphorylation of select signalosome components, thereby betraying signalosome activation.

Signalosome activation is associated with cell differentiation along the myeloid lineage and G1/0 cell cycle arrest. If RA-induced Fgr expression is ablated by a CRISPR-KO; then the RA-induced phosphorylation of NUMB and enhanced NUMB-binding and phosphorylation of select signalosome components are lost. The cells now fail to undergo RA-induced differentiation or G1/0 arrest. In sum, this research team found that NUMB acts as a scaffold for a signaling machine that functions to propel RA-induced differentiation and G1/0 arrest, and that Fgr binding to NUMB turns the function on.

Dr. Andrew Yen from The Cornell University said, "Retinoic acid (RA) is a biologically fundamental regulator of cell proliferation and differentiation [1-3]. It is evolutionarily conserved and has widespread effects in numerous tissues."

It has been found that transcriptional activation by RAR/RXR to control cell differentiation and cell cycle arrest requires MAPK pathway related signaling to enable transcriptional activation necessary for driving cell differentiation/cell cycle G1/0 arrest.

The main finding is that the Numb fate determinant protein appears to act as a scaffold for the signalsome, binding a "spine" of molecules to which all other signalsome molecules are attached; and that RA induced expression of the Fgr SFK and its binding to Numb with phosphorylation> of Numb, as well as other prominent signalsome phosphorylation events, indicating activation of the signalsome.

SLP-76 gets phosphorylated with RA-induced Fgr in parental wt, but not in Fgr KO, cells; so phosphorylation of Slp-76, one of the most prominent RA-induced p-tyr phosphorylations, where Slp-76 is known to IP with Fgr and Lyn, is also associated with Fgr binding Numb.

Numb also binds Lyn, which is known to become Y416 phosphorylated with RA treatment; indicating that Fgr binding Numb is associated with phosphorylation of Lyn, where Slp-76 and Lyn are the closest associates of Fgr in the signalsome force node representation of known IP partners.

In sum the Oncotarget data support a paradigm where signaling molecules bound to a Numb scaffold in a signalsome are activated by RA-induced Fgr expression and its binding to Numb to propel RA-induced differentiation and G1/0 arrest. In essence, RA is ergo increasing the amount of signalsome and increasing the amount of Fgr to activate them, thereby driving the cell to differentiate.

The Yen Research Team concluded in their Oncotarget Research Output that a major challenge to RA differentiation therapy is the emergence of resistance to RA after the initial RA-treatment.

In an attempt to gain insight into how it develops, HL-60 cells resistant to RA were derived by sustained culture in progressively increasing RA concentrations.

A survey of expression of potentially responsible candidate molecules revealed that the biggest divergence between the parental cells and the RA-resistant derivatives was the failure of resistant cells to upregulate Fgr in response to RA.

Using drugs in lieu of Fgr to activate the signalsome in combination with RA may thus be a means of overcoming resistance.

Thus, the paradigm presented here may provide insights on candidates, the dysfunction of which are seminal to resistance.

INFORMATION:

DOI - https://doi.org/10.18632/oncotarget.27969

Full text - https://www.oncotarget.com/article/27969/text/

Correspondence to - Andrew Yen - ay13@cornell.edu

Keywords - retinoic acid(RA), FGR, Numb, non-APL AML, cell differentiation

About Oncotarget

Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105

Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC


[Attachments] See images for this press release:
Oncotarget: Fgr and Numb in retinoic differentiation and G0 arrest of non-APL AML cells

ELSE PRESS RELEASES FROM THIS DATE:

Shedding light on the dark side of firm lobbying

2021-07-23
Researchers from George Mason University, University of Manitoba, Colorado State University, and Georgetown University published a new paper in the Journal of Marketing that examines an unintended customer consequence of lobbying, decreased customer satisfaction, and also explains marketing-focused efforts that can help prevent it. The study, forthcoming in the the Journal of Marketing, is titled "Shedding Light on the Dark Side of Firm Lobbying: A Customer Perspective" and is authored by Gautham Vadakkepatt, Sandeep Arora, Kelly Martin, and Neeru Paharia. Lobbying, ...

Southeastern US herbaria digitize three million specimens, now freely available online

Southeastern US herbaria digitize three million specimens, now freely available online
2021-07-23
A network of over 100 herbaria spread out across the southeastern United States recently completed the herculean task of fully digitizing more than three million specimens collected by botanists and naturalists over a span of 200 years. The project, which was funded by the National Science Foundation, is part of a larger, ongoing effort by natural history institutions worldwide to make their biological collections easily accessible to researchers studying broad patterns of evolution, extinction, range shifts, and climate change. In a END ...

Meet the Martian meteorite hunters

Meet the Martian meteorite hunters
2021-07-23
A team at the Natural History Museum (NHM), London is paving the way for future rovers to search for meteorites on Mars. The scientists are using the NHM's extensive meteorite collection to test the spectral instruments destined for the ExoMars rover Rosalind Franklin, and develop tools to identify meteorites on the surface of the red planet. The project is being presented today (23 July) at the virtual National Astronomy Meeting 2021. The cratered surface of our nearest planetary neighbour has a long and complex history, and searching for rocks amidst more rocks may seem like a futile activity. Despite this, Martian rovers statistically have a significantly higher 'find per mile' success rate than dedicated meteorite hunts on ...

New dietary treatment for epilepsy well tolerated and reduced seizures

2021-07-23
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed. For the study, published in Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed by UCL in collaboration with Royal Holloway, University of London, and Vitaflo International Ltd. The ketogenic diet (KD) consists of high-fat, low-carbohydrate and adequate protein consumption and mimics the fasting state, altering the metabolism to use body fat as the primary fuel source. This switch from carbohydrates to fat for body ...

Martian global dust storm ended winter early in the south

2021-07-23
A dust storm that engulfed Mars in 2018 destroyed a vortex of cold air around the planet's south pole and brought an early spring to the hemisphere. By contrast, the storm caused only minor distortions to the polar vortex in the northern hemisphere and no dramatic seasonal changes. Dr Paul Streeter of The Open University's Faculty of Science, Technology, Engineering and Mathematics will present the work today (23 July) at the virtual National Astronomy Meeting (NAM 2021). Over two weeks at the beginning of June 2018, localised dust storms combined and spread to form an impenetrable blanket of dust that hid almost the entire planet's surface. The global dust storm, ...

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa
2021-07-23
CHAPEL HILL, North Carolina--Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. The economic finding appeared July 22, 2021, in Lancet Global Health. The clinical trial results, reported May 19, 2021, in Lancet Global Health involved 37 people with diffuse large B-cell lymphoma (DLBCL). ...

Advanced bladder cancers respond to immunotherapy regardless of gene mutation status

Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
2021-07-23
CHAPEL HILL, North Carolina--A new study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy treatment in a manner that is similar to patients without that mutation, a discovery that runs counter to previous assumptions. This research, led by scientists at the University of North Carolina Lineberger Comprehensive Cancer Center, has important implications for patients who have not been offered immunotherapy because of their genetic profiles. The findings are published in the British Journal of Cancer. The National Cancer Institute estimates that 83,730 people in the United States will be diagnosed with bladder cancer in 2021, and the disease will cause 17,200 deaths. While the cancer ...

Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing

2021-07-23
ROCHESTER, Minn. -- A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing. The study was published Thursday, July 22, in the Journal of Clinical Oncology. Dr. Couch says that women over 65 rarely qualify for hereditary cancer genetic testing based on current testing guidelines because they are thought to exhibit low rates of genetic mutations in breast cancer genes. "Most studies of breast cancer genes have not looked at older women, those who were diagnosed over the age of 65," says Dr. Couch. He says these studies have mainly tested women with a strong family history of breast ...

Synlogic publishes papers in Nature journals demonstrating proof-of-mechanism and potential of synth

2021-07-22
- Data show dose-responsive, non-saturated increases in gastrointestinal consumption of Phe in humans by SYNB1618 - - SYNB1618 Phase 2 study in patients with PKU ongoing with proof-of-concept readout anticipated in 2H 2021 - - Phase 1 study of SYNB1934, an evolved strain of SYNB1618 in the PKU portfolio, initiated - CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today the publication of two papers in the journals Nature Metabolism and Communications Biology. The publications detail findings ...

Study: Young workers now value respect over 'fun' perks in the workplace

2021-07-22
Millennials, often referred to as the "job-hopping generation," represent a group of young workers who once grabbed the national spotlight with their publicized demands for "fun" work perks, such as happy hours. However, researchers at the Novak Leadership Institute at the University of Missouri and Kansas State University discovered today's young workers -- ages 21-34 -- represent a life-stage shift toward placing more value on having respectful communication in the workplace over trendy work perks. "Millennials have been called the 'entitled generation,' and they kind of give young workers a bad rap because their often-publicized interests ...

LAST 30 PRESS RELEASES:

Study reveals erasing inequality could prevent hundreds of adverse births annually in major UK city

No “uncanny valley” effect in science-telling AI avatars

New UNCG research shows southern shrews shrink in winter

Children exposed to brain-harming chemicals while sleeping

Emotions and levels of threat affect communities’ resilience during extreme events

New CONSORT reporting guidelines published today in five medical journals

Experts stress importance of vaccination amidst measles outbreaks

Enabling stroke victims to 'speak': $19 million toward brain implants to be built at U-M

Study captures sharp uptake in use of new weight loss and glucose-lowering medications

Van Andel Institute to recognize Dr. J. Timothy Greenamyre with 2025 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research

One firearm injury was treated every 30 minutes in emergency departments in a study of 10 jurisdictions

The gut health benefits of sauerkraut

Children’s Hospital of Philadelphia researchers chart natural history of patients with SCN8A-related disorders

Archaeologists measured and compared the size of 50,000 ancient houses to learn about the history of inequality -- they found that it’s not inevitable

Peptide imitation is the sincerest form of plant flattery

Archaeologists discover historical link between inequality and sustainability

Researchers develop an LSD analogue with potential for treating schizophrenia

How does our brain regulate generosity?

New study reveals wealth inequality’s deep roots in human prehistory

New archaeological database reveals links between housing and inequality in ancient world

New, non-toxic synthesis method for “miracle material” MXene

Cutting-edge optical genome mapping technology shows promise for diagnosis, prognosis, and therapeutic options of multiple myeloma

Study looks at impact of COVID-19 pandemic on rates of congenital heart disease procedures among children

UH researcher unveils new model to evaluate impact of extreme events and natural hazards

Illegal poisonings imperil European raptors and could disrupt ecosystem health

UF professor develops AI tool to better assess Parkinson’s disease, other movement disorders

Computer science professor elected AAAS Fellow

Learning about social interaction by studying dancing

Immune cell 'messengers' could save crumbling bones - new hope for joint pain sufferers

Fishing for cephalopod DNA allows for efficient marine surveying

[Press-News.org] Oncotarget: Fgr and Numb in retinoic differentiation and G0 arrest of non-APL AML cells
In sum the Oncotarget data support a paradigm where signaling molecules bound to a Numb scaffold in a signalsome are activated by RA-induced Fgr expression